AllianceBernstein Holding LP (AB)

24.75
0.10 0.41
NYSE : Financial
Prev Close 24.65
Open 24.80
Day Low/High 24.60 / 24.85
52 Wk Low/High 20.40 / 25.12
Volume 126.05K
Avg Volume 478.80K
Exchange NYSE
Shares Outstanding 96.47M
Market Cap 2.38B
EPS 2.20
P/E Ratio 11.47
Div & Yield 1.84 (7.50%)

Latest News

AllianceBernstein's Biggest Holder Saw Ex-CEO as Wrong Guy -- With Right Ideas

AllianceBernstein's Biggest Holder Saw Ex-CEO as Wrong Guy -- With Right Ideas

New Alliance Bernstein CEO Seth Bernstein and executives of major shareholder AXA have indicated they're inclined to keep former chief Peter Kraus's strategies, despite his unceremonious dismissal.

Mutual Funds Lost $5.4 Billion in Puerto Rico, WSJ Says

Mutual Funds Lost $5.4 Billion in Puerto Rico, WSJ Says

Puerto Rico is currently in what amounts to municipal bankruptcy court.

AXA Shares Jump After US IPO Plans Follow Ousting of AllianceBernstein's Peter Kraus

AXA Shares Jump After US IPO Plans Follow Ousting of AllianceBernstein's Peter Kraus

Axa, Europe's second largest. insurer will sell a minority stake in its US operations after ousting AllianceBernstein CEO Peter Kraus.

AllianceBernstein CEO Kraus Fired Along With All Independent Board Members

AllianceBernstein CEO Kraus Fired Along With All Independent Board Members

Peter Kraus becameCEO in 2008.

Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More

Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More

Here are Wednesday's top research calls, including an upgrade for Lululemon and new coverage of L Brands, Masco and Under Armour.

AB Expands Multi-Asset Solutions Platform With Industry Veteran New Hire

Newly-created role supports firm's continued expansion of its multi-asset solutions business driven by client demand for outcome oriented solutions

Beyond Bitcoin: Big Banks Test Out Blockchain Technology

Beyond Bitcoin: Big Banks Test Out Blockchain Technology

Fourteen banks tested blockchain technology in the syndicated loan market, and benefits were seen.

AB Science Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The European Medicines Agency

AB Science Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The European Medicines Agency

Filing of masitinib in the treatment of amyotrophic lateral sclerosis (ALS) to the European Medicines Agency (EMA)

Align With AllianceBernstein for Income

Align With AllianceBernstein for Income

This master limited partnership offers high cash payout without taking on undue risk.

Don't Miss Out: Top 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

Don't Miss Out: Top 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

These 3 dividend stocks are rated a Buy by TheStreet

Best 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

Best 3 Yielding Buy-Rated Stocks: NEWT, AB, CORR

These 3 dividend stocks are rated a Buy by TheStreet